Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 235 across all filing types
Latest filing 2025-03-27 Legal Proceedings Report
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Legal Proceedings Report Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a Notice of Demand issued by the Income Tax Department, detailing litigation and financial implications related to tax demand. The document is a regulatory announcement about a legal proceeding rather than a full report or financial statement. It does not contain financial statements or detailed financial analysis, nor is it a report publication announcement. The content fits best under Legal Proceedings Report (LTR) as it updates on a significant legal matter involving the company.
2025-03-27 English
Allotment of Securities
Board/Management Information Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding corporate governance matters. It details the appointment of a new Independent Director, cessation of an existing Independent Director, and allotment of shares upon exercise of employee stock options. The references to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, and the detailed disclosures about director appointments and share allotments, indicate this is an announcement of changes in the company's board and capital structure. The document does not contain financial statements or comprehensive financial analysis, nor is it a report or presentation. It is primarily an announcement of board/management changes and share allotment events. Therefore, the most appropriate classification is Board/Management Information (MANG).
2025-03-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges about the closure of the trading window for insiders ahead of the announcement of audited financial results for the quarter and year ending March 31, 2025. It references the upcoming board meeting to approve these results but does not contain any financial data or the results themselves. The document is a regulatory announcement related to insider trading compliance and timing of financial results disclosure. It is short (2282 characters) and serves as a notification rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-03-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 25 March 2025, informing stock exchanges about a scheduled meeting with an analyst/investor. It explicitly states that no new presentation will be made and that the company does not intend to discuss unpublished price sensitive information. The document is an intimation or announcement of an upcoming investor meeting rather than a detailed investor presentation or financial report. It is also quite short (2133 characters) and serves as a regulatory disclosure under SEBI listing obligations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled meeting with an analyst/investor. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of a meeting schedule rather than a financial report, presentation, or detailed disclosure. It is also quite short (2125 characters), and does not contain financial data, management discussion, or regulatory filings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-25 English
Cessation
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. It announces the appointment of a new Independent Director, cessation of an existing Independent Director, and allotment of shares upon exercise of ESOP options. The document includes detailed disclosures about the director's appointment and cessation, as well as specifics about the share allotment under ESOP 2008. There are no financial statements or comprehensive financial data presented, nor is this a report or presentation. The content is focused on board/management changes and share allotment disclosures. Therefore, the document fits best under the category of Board/Management Information (MANG), as it primarily announces changes in the company's board of directors and related disclosures.
2025-03-24 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.